Affordable Medicines
June 18, 2019
Biosimilars: Not Simply Generics
With the entry of biosimilars into the U.S. market, it is important for pharmacists to understand these products and how they differ from generic medications.June 17, 2019
FDA Update on Recent Voluntary ARB Drug Recalls
January 23, 2019
Existing Drugs, Not Just New, Play Large Role in Price Increases
September 5, 2018
For Combo Drugs, the Whole Can Be More Expensive Than the Parts
June 15, 2018
Oral PDE5 Inhibitors for Erectile Dysfunction
May 18, 2018
Navigating the Generic Regulatory Landscape
October 13, 2017
Biosimilar Milestone
June 16, 2017
Generic Drugs in the Pipeline: 2017 Update
June 16, 2017
An Overview of Generic Triptans for Migraine
June 16, 2017
AAM Update on the Status of Generic Drugs
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.